Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Pathological and physiological roles of the MutL-gamma (MLH1-MLH3) nuclease: from harmful trinucleotide repeat expansions to promoting diversity in meiosis

Ziel

The function of the well-known mismatch repair (MMR) is to correct mispairs and misalignments arising during DNA replication. Canonical MMR is dependent on MutLa, a nuclease consisting of MLH1 and PMS2 subunits. In addition to MutLa, human cells also contain the MutLg (MLH1-MLH3) nuclease, implicated in pathological trinucleotide repeat expansion and the processing of meiotic DNA recombination intermediates. Despite the biological and clinical importance of MutLg, its involvement in these processes remains poorly understood.

In Aim I, we will elucidate how MutLg and co-factors recognize and process secondary DNA structures formed within repetitive trinucleotide sequences to understand repeat expansion and protective mechanisms. In Aim II, we will define the functional role of MutLg and co-factors in resolving meiotic recombination intermediates, specifically how they cleave DNA structures such as Holliday junctions to yield crossover recombination products.

Our preliminary data indicate that the non-canonical MMR complexes dependent on MutLg are regulated very differently compared to the classical MMR factors, both in terms of the secondary DNA structures and the protein co-factors involved. The unexpected diversity of the regulatory mechanisms will offer exciting insights into how the various MMR complexes adapted to carry out distinct cellular functions in very different physiological contexts. We will employ robust biochemical reconstitution strategies, combined with advanced single-molecule imaging, enabling direct visualization of MutLg interactions and activity in real-time. Our approach overcomes previous technical barriers through optimized production of recombinant MutLg and specialized DNA substrates. By clarifying the mechanisms underlying MutLg’s diverse roles, this project will advance our understanding of fundamental biological processes and provide potential prospects for targeted treatment for Huntigton's and related disorders.

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-ERC - HORIZON ERC Grants

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) ERC-2025-ADG

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Gastgebende Einrichtung

FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA
Netto-EU-Beitrag
€ 3 293 900,00
Adresse
VIA FRANCESCO CHIESA 5
6500 Bellinzona
Schweiz
Region
Schweiz/Suisse/Svizzera Ticino Ticino
Aktivitätstyp
Research Organisations
Links
Gesamtkosten
Keine Daten

Begünstigte (1)